Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602809 · ClinicalTrials.gov registry record
Microvessels and Heart Problems in Sickle Cell Disease
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 65
- Enrollment target
NCT01602809 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 65 participants.
The verdict
NCT01602809 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Background: \- Small blood vessels (microvessels) in many different organs are affected by diseases such as diabetes and atherosclerosis. These microvessels may also be abnormal in people who have sickle cell disease. Stiffness of the red blood cells leads to problems in the microvessels of the heart and kidneys. However, these problems may not be detected until these organs are severely affected. Researchers want to study problems with microvessels in people with and without sickle cell disease. Objectives: \- To study how microvessels in the heart and other organs are affected by sickle cell disease. Eligibility: * Individuals at least 18 years of age who have sickle cell disease. * Healthy volunteers at least 18 years of age. Design: * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. * All participants will have about 3 to 4 hours of testing for the study. Participants with sickle cell disease who are having a pain crisis at the time they enter the study may be asked to have the testing again when the crisis is over. The repeat testing will occur at least 4 weeks after the pain crisis ends. * All participants will have the following tests: * Blood draws to check kidney and liver function, and other blood tests * Measure of blood flow in the brachial (upper arm) artery * Heart ultrasound * Ultrasound scans of arm muscles to study blood flow * Ultrasound scans after taking vasodilators to increase blood flow * Healthy volunteers will also have a magnetic resonance imaging scan. It will show blood flow in the heart. This scan will involve another dose of a vasodilator.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2012-04-30 |
| Est. Completion | 2017-10-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01602809
The ClinicalTrials.gov registry entry for NCT01602809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01602809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01602809 about?
NCT01602809 is a clinical study titled "Microvessels and Heart Problems in Sickle Cell Disease". Background: \- Small blood vessels (microvessels) in many different organs are affected by diseases such as diabetes and atherosclerosis. These microvessels may also be abnormal in people who have sickle cell disease. Stiffness of the red blood cells leads to problems in the microvessels of the hea...
What is the current status of trial NCT01602809?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2012-04-30. Estimated completion is 2017-10-25.
Who is sponsoring clinical trial NCT01602809?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.